Use-Results Survey for ORENCIA® Subcutaneous Injection 125mg Syringe 1mL
NCT02600455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 505
Last updated 2017-01-13
Summary
The purpose of this study to collect information on the safety, especially localized injection site reactions, and efficacy of ORENCIA Subcutaneous Injection 125mg Syringe 1mL in patients with rheumatoid arthritis.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
-
Ono Pharmaceutical Co. Ltd
collaborator INDUSTRY - lead INDUSTRY
Principal Investigators
-
Bristol Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- Japan
More Related Trials
-
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
NCT05782335 ·Status: RECRUITING
-
Dose Escalation With Remicade® and Orencia®
NCT01141413 ·Status: COMPLETED
-
Assessment of the Effectiveness of IV and SC Abatacept (Orencia) Patient Alert Cards in Patients With Rheumatoid Arthritis in a Sample of EU Countries
NCT02632890 ·Status: COMPLETED
-
A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis
NCT00134693 ·Status: COMPLETED ·Phase: PHASE2
-
Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis
NCT00213538 ·Status: COMPLETED
-
Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis
NCT01717846 ·Status: WITHDRAWN ·Phase: PHASE4
-
Predictors of Adherence to Orencia
NCT01136707 ·Status: COMPLETED
-
Study Evaluating the Efficacy and Safety of Etanercept
NCT00546533 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)
NCT00746512 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
NCT00245934 ·Status: COMPLETED
-
Enbrel Liquid Immunogenicity Protocol
NCT00249041 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
NCT03932344 ·Status: COMPLETED
-
Study Evaluating the Safety of Enbrel (Etanercept)
NCT00683384 ·Status: COMPLETED
-
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
NCT00110903 ·Status: COMPLETED ·Phase: PHASE3
-
Kineret in the Treatment of Rheumatoid Arthritis
NCT02915094 ·Status: COMPLETED
-
Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes
NCT00094341 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate
NCT00619905 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
NCT00688545 ·Status: TERMINATED
-
Juvenile Rheumatoid Arthritis
NCT00037648 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis
NCT00346294 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy
NCT00076206 ·Status: TERMINATED ·Phase: PHASE2
-
Diagnostic Value of Oral Prednisolone Test for Rheumatoid Arthritis
NCT01395251 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety Study of a Single Dose of REGN88(SAR153191)in Patients With Rheumatoid Arthritis
NCT01055899 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission
NCT02373813 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00505089 ·Status: TERMINATED ·Phase: PHASE1/PHASE2